We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

15 hedge funds and large institutions have $2.19M invested in Capricor Therapeutics in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

7% more funds holding

Funds holding: 14 → 15 (+1)

24% less capital invested

Capital invested by funds: $2.9M → $2.19M (-$708K)

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$327K
2
Baird Financial Group
Baird Financial Group
Wisconsin
+$59.2K
3
AllianceBernstein
AllianceBernstein
Tennessee
+$44.5K
4
Morgan Stanley
Morgan Stanley
New York
+$23.1K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$13.2K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$596K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$68K
3
SM
Sabby Management
Florida
-$35.4K
4
KTC
Kistler-Tiffany Companies
Pennsylvania
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.01M -$35.4K -795 -3%
Goldman Sachs
2
Goldman Sachs
New York
$558K +$327K +7,342 +114%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$177K – – –
Morgan Stanley
4
Morgan Stanley
New York
$169K +$23.1K +518 +14%
Millennium Management
5
Millennium Management
New York
$75K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$61K +$13.2K +297 +24%
Baird Financial Group
7
Baird Financial Group
Wisconsin
$54K +$59.2K +1,330 New
AllianceBernstein
8
AllianceBernstein
Tennessee
$41K +$44.5K +1,000 New
PA
9
Perceptive Advisors
New York
$16K – – –
CFN
10
Cordasco Financial Network
Florida
$13K – – –
UBS Group
11
UBS Group
Switzerland
$11K +$5.83K +131 +89%
BIM
12
BlackRock Investment Management
Delaware
$2K – – –
GC
13
Globeflex Capital
California
$1K +$623 +14 New
Walleye Trading
14
Walleye Trading
New York
$1K +$891 +20 New
BC
15
Broadfin Capital
New York
– -$596K -11,800 Closed
Bank of Montreal
16
Bank of Montreal
Ontario, Canada
– -$68K -1,349 Closed
KTC
17
Kistler-Tiffany Companies
Pennsylvania
– -$1K -14 Closed
Wells Fargo
18
Wells Fargo
California
– +$45 +1 New

CAPR Hedge Fund Activity: Q3 2015 in Review

15 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q3 2015, worth a combined $2.19M — down 24% from $2.9M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CAPR positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $327K. The largest seller was Broadfin Capital, exiting entirely with an estimated $596K sold.

  • 15 institutional investors held Capricor Therapeutics (CAPR) as of Q3 2015, up from 14 in Q2 2015.
  • Funds reported $2.19M of Capricor Therapeutics stock for Q3 2015, down 24% quarter-over-quarter.
  • 5 funds opened new Capricor Therapeutics positions in Q3 2015 and 4 closed out, a net change of +1 holder.
  • The largest Capricor Therapeutics buyer in Q3 2015 was Goldman Sachs, an estimated $327K added.
  • The largest Capricor Therapeutics seller in Q3 2015 was Broadfin Capital, an estimated $596K sold.

Based on aggregated 13F filings for Q3 2015.